Search research articles
Contact Us
Filters
Showing results (201-210 of 217) with videos related to
Page
of 22
Sort By:
Cardio-Oncology (London, England)
|
March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group
Lisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Cancer
|
May 12, 2017
Clinical trial enrollment of adolescents and young adults with sarcoma
Lara E Davis, Katherine A Janeway, Aaron R Weiss, et al.
Journal of Adolescent and Young Adult Oncology
|
February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
Susan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
March 8, 2016
[The flexibility of family medicine]
C Minguet, A Aubrege, M Aubart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2023
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Eric J Chow, Sanjeev Aggarwal, David R Doody, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2025
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study
J N Graff, M Burotto, P C Fong, et al.
Journal of Personality Assessment
|
March 26, 2020
Measuring Implicit Motives with the Picture Story Exercise (PSE): Databases of Expert-Coded German Stories, Pictures, and Updated Picture Norms
Felix D Schönbrodt, Birk Hagemeyer, Veronika Brandstätter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2025
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study
C Gratzke, M Özgüroğlu, A Peer, et al.
Journal of Adolescent and Young Adult Oncology
|
September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.
ESMO Open
|
July 6, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study)
G Roviello, F Ciccimarra, F Urabe, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 217) with videos related to
Sort By:
Page
of 22
Cardio-Oncology (London, England)
|
March 11, 2020
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group
Lisa M Kopp, Richard B Womer, Cindy L Schwartz, et al.
Cancer
|
May 12, 2017
Clinical trial enrollment of adolescents and young adults with sarcoma
Lara E Davis, Katherine A Janeway, Aaron R Weiss, et al.
Journal of Adolescent and Young Adult Oncology
|
February 1, 2023
Joint Adult and Pediatric Working Group as a Successful Platform to Strengthen Adolescent and Young Adult (AYA) Clinical Trial Collaboration: A Report from the NCTN/SARC AYA Clinical Trials Sarcoma Working Group
Susan L Whiteway, Aaron R Weiss, Safia K Ahmed, et al.
Bulletin De La Societe Des Sciences Medicales Du Grand-Duche De Luxembourg
|
March 8, 2016
[The flexibility of family medicine]
C Minguet, A Aubrege, M Aubart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 20, 2023
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer
Eric J Chow, Sanjeev Aggarwal, David R Doody, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2025
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resistant prostate cancer: the randomized, double-blind, phase III KEYNOTE-641 study
J N Graff, M Burotto, P C Fong, et al.
Journal of Personality Assessment
|
March 26, 2020
Measuring Implicit Motives with the Picture Story Exercise (PSE): Databases of Expert-Coded German Stories, Pictures, and Updated Picture Norms
Felix D Schönbrodt, Birk Hagemeyer, Veronika Brandstätter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 18, 2025
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study
C Gratzke, M Özgüroğlu, A Peer, et al.
Journal of Adolescent and Young Adult Oncology
|
September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321
Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.
ESMO Open
|
July 6, 2026
Real-world prognostic assessment of the HERO score in metastatic urothelial carcinoma treated with enfortumab vedotin (ARON-2EV study)
G Roviello, F Ciccimarra, F Urabe, et al.
Page
of 22